Why Are Shares Of Azitra Rising?

Azitra entered a securities purchase agreement to raise up to $31.4M in gross proceeds from healthcare-focused institutional investors. The financing includes Series B and C warrants exercisable at $0.123 per share and Series A convertible preferred priced at $1,000 per share; the deal has driven a share-price spike but may introduce dilution depending on warrant exercises and conversion mechanics.

Analysis

Azitra entered a securities purchase agreement to raise up to $31.4M in gross proceeds from healthcare-focused institutional investors. The financing includes Series B and C warrants exercisable at $0.123 per share and Series A convertible preferred priced at $1,000 per share; the deal has driven a share-price spike but may introduce dilution depending on warrant exercises and conversion mechanics.